Advertisement
IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
Pred 802 dňami
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
Pred 1068 dňami
Canadian Dollar Drops Against Most Majors
The Canadian dollar fell against its most major counterparts in the New York session on Friday.
RTTNews
|
Pred 1 h 46 min
Swiss Market Settles Moderately Lower
The Switzerland market ended weak on Friday, in line with markets across Europe, as investors chose to trim down positions at several counters, continuing to react to earnings updates and assessing the developments on the trade front.
RTTNews
|
Pred 6 h 8 min
European Markets Close Weak After Cautious Session
European markets closed weak on Friday, as investors reacted to a slew of earnings updates, regional economic data, and continued to assess the recent policy announcements from major central banks, and the developments on the trade front.
RTTNews
|
Pred 6 h 32 min
Canadian Market Marginally Down As Stocks Swings Between Gains And Losses
After an early upmove and a subsequent fall into negative territory, the Canadian market recovered a bit on Friday, but slipped again in cautious trade.
RTTNews
|
Pred 7 h 19 min
Chicago Business Barometer Climbs More Than Expected But Still Indicates Contraction
A reading on Chicago-area business activity increased by more than expected in the month of October but continued to indicate contraction, according to a report released by MNI Indicators on Friday. The report said the Chicago business barometer climbed to 43.8 in October after slipping to 40.6 in September. Economists had expected the index to show a more modest increase to 42.3.
RTTNews
|
Pred 10 h 15 min
Eurozone Inflation Softens On Energy Prices
Eurozone inflation softened in October largely due to the fall in energy prices, while core consumer prices registered a steady growth, official data revealed Friday. The harmonized index of consumer prices rose 2.1 percent on a yearly basis, following a 2.2 percent rise in September, flash estimate from Eurostat showed. Inflation came in line with expectations.
RTTNews
|
Pred 10 h 52 min
